BNP Paribas Financial Markets’s Evogene EVGN Stock Holding History
Bought
Maintained
Sold
Other funds holding EVGN
HF
XT
DSC
FDCDDQ
SWM
SS
BNP Paribas Financial Markets's EVGN Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Evogene (EVGN) stake by 69% in Q2 2026, selling an estimated $4.36K and leaving 2,830 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #5577.
BNP Paribas Financial Markets first reported a position in EVGN in Q2 2022 and has held it in 16 quarters since. The position peaked at $68.5K in Q1 2024. 12 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.
- BNP Paribas Financial Markets held 2,830 shares of Evogene worth $1.24K as of Q2 2026.
- BNP Paribas Financial Markets sold 6,294 Evogene shares in Q2 2026, an estimated $4.36K.
- Evogene made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5577 holding.
- BNP Paribas Financial Markets first reported a position in Evogene in Q2 2022 and has held it in 16 quarters since.
- BNP Paribas Financial Markets's Evogene position peaked at $68.5K in Q1 2024.
- 12 funds tracked by Wall St. Rank held Evogene as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.